|Videos|December 29, 2022
Adverse Events Tied to Treatment for Myeloproliferative Neoplasms
Author(s)Ruben Mesa, M.D., Rami S. Komrokji, M.D.
Expert perspectives on the possible adverse events patients may encounter while receiving treatment for myeloproliferative neoplasms.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia
2
Cancer Experts Share Emerging Treatments Patients Should Know in 2026
3
FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer
4
Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO
5
